{"id":"W2549137967","doi":"10.1002/ijc.30533","title":"Development of crizotinib, a rationally designed tyrosine kinase inhibitor for non‐small cell lung cancer","year":2016,"lang":"en","type":"review","venue":"International Journal of Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Crizotinib; Medicine; Lung cancer; Clinical trial; Tyrosine-kinase inhibitor; Oncology; Internal medicine; Anaplastic lymphoma kinase; Drug development; Tyrosine kinase; Targeted therapy; ALK inhibitor; Cancer; Drug; Pharmacology; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003387228,0.0006400006,0.000897203,0.001570213,0.0002525862,0.0006028351,0.000602163,0.0006576605,0.002189206],"category_scores_gemma":[0.0004023264,0.000251969,0.0005257294,0.001300573,0.000255702,0.000792839,0.0004188196,0.001486722,0.001491323],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005041254,"about_ca_system_score_gemma":0.0008399604,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001197152,"about_ca_topic_score_gemma":0.002704864,"domain_scores_codex":[0.999864,0.00001778075,0.00001632494,0.00002447049,0.00006257937,0.00001489252],"domain_scores_gemma":[0.9999168,0.00002894057,0.0000155523,0.000002707378,0.00002557116,0.00001046687],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0000966981,0.0001147779,0.0002179071,0.02296087,0.0001706036,0.0003255387,0.00007289186,0.0007851448,0.007032606,0.006496757,0.0332916,0.9284347],"study_design_scores_gemma":[0.00003824645,0.0001428296,0.0005992893,0.00180271,0.0001289001,0.001237625,0.00003185129,0.0001675923,0.001727681,0.001156927,0.9929482,0.00001819367],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003819848,0.9970281,0.0002502498,0.0002259877,0.0001512621,0.0000139902,0.00004608361,0.00001146886,0.001890876],"genre_scores_gemma":[0.001642188,0.9966891,0.0003613704,0.0001807809,0.00005132217,0.00001028786,0.00006267685,0.000001728183,0.001000453],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002189206,"threshold_uncertainty_score":0.007323682,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03647996718676179,"score_gpt":0.4127008107511185,"score_spread":0.3762208435643567,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}